Literature DB >> 21592751

Development and evaluation of orally disintegrating tablets (ODTs) containing Ibuprofen granules prepared by hot melt extrusion.

Andreas Gryczke1, Silke Schminke, Mohammed Maniruzzaman, Julien Beck, Dennis Douroumis.   

Abstract

In the current study Ibuprofen was embedded in a methacrylate copolymer (Eudragit® EPO) matrix to produce solid dispersions by hot-melt extrusion (HME) processing. The obtained granules were incorporated in orally disintegrating tablets (ODTs). The tablets were developed by varying the ratio of superdisintegrants such as sodium croscarmellose and crosslinked polyvinylpyrrolidone grades while a direct compression process was used to compress the ODTs under various compaction forces to optimize tablet robustness. The properties of the compressed tablets which included porosity, hardness, friability and dissolution profiles were further evaluated and compared with Nurofen® Meltlet ODTs. The taste and sensory evaluation in human volunteers demonstrated excellence in masking the bitter active and improved tablet palatability. Crown
Copyright © 2011. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21592751     DOI: 10.1016/j.colsurfb.2011.04.007

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  20 in total

Review 1.  Hot-Melt Extrusion: from Theory to Application in Pharmaceutical Formulation.

Authors:  Hemlata Patil; Roshan V Tiwari; Michael A Repka
Journal:  AAPS PharmSciTech       Date:  2015-07-10       Impact factor: 3.246

2.  Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.

Authors:  Anjali Agrawal; Mayur Dudhedia; Weibin Deng; Kevin Shepard; Li Zhong; Edward Povilaitis; Ewa Zimny
Journal:  AAPS PharmSciTech       Date:  2016-01-12       Impact factor: 3.246

3.  3D Printed "Starmix" Drug Loaded Dosage Forms for Paediatric Applications.

Authors:  Nicolaos Scoutaris; Steven A Ross; Dennis Douroumis
Journal:  Pharm Res       Date:  2018-01-16       Impact factor: 4.200

4.  Development and Evaluation of Cocoa Butter Taste Masked Ibuprofen Using Supercritical Carbon Dioxide.

Authors:  Rana Obaidat; Haneen Aleih; Hadeia Mashaqbeh; Bashar Altaani; Mo'tasem M Alsmadi; Mohammad Alnaief
Journal:  AAPS PharmSciTech       Date:  2021-03-14       Impact factor: 3.246

Review 5.  Twin-screw extrusion of sustained-release oral dosage forms and medical implants.

Authors:  Xin Feng; Feng Zhang
Journal:  Drug Deliv Transl Res       Date:  2018-12       Impact factor: 4.617

6.  Novel Controlled Release Polymer-Lipid Formulations Processed by Hot Melt Extrusion.

Authors:  Mohammed Maniruzzaman; Muhammad T Islam; Sheelagh Halsey; Devyani Amin; Dennis Douroumis
Journal:  AAPS PharmSciTech       Date:  2015-12-21       Impact factor: 3.246

7.  Development of taste masked caffeine citrate formulations utilizing hot melt extrusion technology and in vitro-in vivo evaluations.

Authors:  Manjeet B Pimparade; Joseph T Morott; Jun-Bom Park; Vijay I Kulkarni; Soumyajit Majumdar; S N Murthy; Zhuoyang Lian; Elanor Pinto; Vivian Bi; Thomas Durig; Reena Murthy; H N Shivakumar; K Vanaja; P C Kumar; Michael A Repka
Journal:  Int J Pharm       Date:  2015-04-15       Impact factor: 5.875

8.  Rat Palatability Study for Taste Assessment of Caffeine Citrate Formulation Prepared via Hot-Melt Extrusion Technology.

Authors:  Roshan V Tiwari; Ashley N Polk; Hemlata Patil; Xingyou Ye; Manjeet B Pimparade; Michael A Repka
Journal:  AAPS PharmSciTech       Date:  2015-11-16       Impact factor: 3.246

Review 9.  Physical approaches to masking bitter taste: lessons from food and pharmaceuticals.

Authors:  John N Coupland; John E Hayes
Journal:  Pharm Res       Date:  2014-09-10       Impact factor: 4.200

10.  Preparation and Evaluation of Hot-Melt Extruded Patient-Centric Ketoprofen Mini-Tablets.

Authors:  Abdullah S Alshetaili; Bjad K Almutairy; Roshan V Tiwari; Joseph T Morott; Sultan M Alshehri; Xin Feng; Bader B Alsulays; Jun-Bom Park; Feng Zhang; Michael A Repka
Journal:  Curr Drug Deliv       Date:  2016       Impact factor: 2.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.